1. Guest, the 'News in Brief' for the week beginning 13th March 2023 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

omalizumab

  1. Andy
    Thread

    Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial, 2017, Chinthrajah et al

    Summary Background Despite progress in single food oral immunotherapy, there is little evidence concerning the safety and efficacy of treating...
    Thread by: Andy, Dec 17, 2017, 0 replies, in forum: Other health news and research
Showing results 1 to 1 of 1